Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Estradiol
Drug ID BADD_D00821
Description Estradiol is a naturally occurring hormone circulating endogenously in females. It is commercially available in several hormone therapy products for managing conditions associated with reduced estrogen, such as vulvovaginal atrophy and hot flashes. Some available forms of estradiol include oral tablets, injections, vaginal rings, transdermal patches, sprays, gels, and creams.[L11485,L11488,L11491, L11494,L11497,L11500,L11503] When used for oral or IM administration, estradiol is commonly synthesized as a pro-drug ester (such as [DB13952], [DB13953], [DB13954], [DB13955], and [DB13956]). Because it has a low oral bioavailability on its own, estradiol is commonly formulated with an ester side-chain. [DB00977] (EE) is a synthetic form of estradiol commonly used as the estrogenic component of most combination oral contraceptive pills (OCPs). Ethinyl estradiol is different from estradiol due to its higher biovailability and increased resistance to metabolism, rendering it more suitable for oral administration.
Indications and Usage Estradiol is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy due to menopause, for the treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure, and for the prevention of post-menopausal osteoarthritis. It is also used for the treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease, and for the treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only).
Marketing Status Prescription; Discontinued
ATC Code G03CA03
DrugBank ID DB00783
KEGG ID D00105
MeSH ID D004958
PubChem ID 5757
TTD Drug ID D08QMX
NDC Product Code 76420-022; 0430-0721; 63629-4788; 43063-706; 0781-7119; 0169-5176; 70518-0920; 70934-541; 54348-702; 43063-717; 72189-183; 68788-7961; 38779-2261; 46144-400; 69238-1294; 0781-7104; 68025-066; 0378-4640; 70518-2595; 61919-195; 72189-198; 71335-0797; 50090-3645; 52483-9104; 0430-3754; 0023-5886; 0093-3223; 63083-1557; 42291-962; 60429-833; 0395-8065; 11014-0320; 11014-0321; 51862-334; 69238-1296; 0093-3541; 0574-2067; 65162-126; 68025-067; 65162-992; 0013-2150; 61919-278; 63629-8803; 42806-089; 0378-4641; 68788-7892; 70518-2829; 70934-215; 50261-110; 0378-3349; 68788-8063; 68968-6675; 69238-1295; 0378-4643; 49452-2801; 0078-0344; 0430-0722; 63539-021; 68788-7332; 68025-065; 12860-0218; 50090-5494; 0802-8065; 60429-834; 63629-8804; 0378-4620; 70934-506; 0781-7138; 68968-6637; 76420-680; 51862-332; 69238-1447; 68968-3437; 68071-2487; 71335-1973; 65162-993; 76420-023; 70518-2368; 0078-0343; 50419-453; 0378-4621; 0430-0720; 68025-083; 65162-995; 52483-9254; 0378-8770; 71335-1488; 52483-9504; 70518-2369; 0555-0887; 0078-0365; 68968-3410; 60870-0218; 24658-702; 0378-3361; 68462-711; 71335-0430; 24658-703; 0555-0899; 0378-3352; 51862-333; 69238-1629; 68968-3475; 0378-3360; 71335-0201; 48087-0159; 70934-927; 0781-7122; 66993-002; 71335-0226; 65162-989; 68968-6650; 54348-701; 17139-617; 68981-012; 65162-150; 65162-226; 60429-835; 47781-104; 0078-0345; 44132-009; 50419-455; 24658-704; 0378-4644; 0781-7133; 51552-0384; 50419-456; 69238-1631; 50090-1704; 50419-459; 76420-681; 53746-226; 50419-451; 0023-5887; 68025-086; 68071-2429; 0555-0886; 69238-1630; 63629-8802; 0781-7134; 65162-228; 76420-021; 68071-3394; 45541-1124; 70934-393; 50419-454; 0023-5888; 69238-1632; 68968-3450; 0378-4623; 50090-3327; 65162-997; 0781-7156; 68788-7102; 42291-426; 0378-3350; 42806-087; 0378-4642; 71335-0445; 69238-1293; 0115-1518; 0037-4801; 63629-8654; 0023-5885; 69238-1633; 0781-7136; 50261-104; 71335-1719; 70934-798; 63629-8713; 65162-148; 68968-6625; 0078-0346; 50419-452; 42806-088; 68968-6610; 38779-0869; 45802-097; 63187-741; 68981-013; 0781-7129; 0378-3351; 0378-4622; 76420-048; 50090-2321; 68968-3425; 65162-149; 70934-786; 0378-4619; 0781-7167; 70518-0834; 44132-001; 0781-7144
Synonyms Estradiol | Estradiol-17 beta | Estradiol 17 beta | Estradiol Anhydrous | Oestradiol | Estradiol-17beta | Estradiol 17beta | 17 beta-Estradiol | 17 beta Estradiol | 17 beta-Oestradiol | 17 beta Oestradiol | Progynova | Estradiol, (9 beta,17 alpha)-Isomer | Estradiol, (9 beta,17 beta)-Isomer | Estradiol, Monosodium Salt | Estradiol, Sodium Salt | Vivelle | Aerodiol | Estrace | Estraderm TTS | Estradiol Hemihydrate | Estradiol Hemihydrate, (17 alpha)-Isomer | Estradiol Monohydrate | Estradiol, (+-)-Isomer | Estradiol, (-)-Isomer | Estradiol, (16 alpha,17 alpha)-Isomer | Estradiol, (16 alpha,17 beta)-Isomer | Estradiol, (8 alpha,17 beta)-(+-)-Isomer | Estradiol, (8 alpha,17 beta)-Isomer | Estradiol Valerate | Estradiol Valeriante | Progynon-Depot | Progynon Depot | Delestrogen | Estradiol-17 alpha | Estradiol 17 alpha | Estradiol, (17-alpha)-Isomer | Ovocyclin
Chemical Information
Molecular Formula C18H24O2
CAS Registry Number 17916-67-5
SMILES CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anorectal discomfort07.03.03.0030.000139%Not Available
Vulvovaginal pain21.08.02.0090.002642%
Abnormal withdrawal bleeding08.06.02.001; 21.01.01.008--Not Available
Acute kidney injury20.01.03.016--
Vulvovaginal erythema21.08.02.011; 23.03.06.0170.000348%Not Available
Toxicity to various agents12.03.01.046--Not Available
Vulvovaginal swelling21.08.02.0160.000278%Not Available
Medication residue present13.15.01.0320.000348%Not Available
Candida infection11.03.03.021--
Mouth swelling07.05.04.007; 10.01.05.020; 23.04.01.0200.000139%Not Available
Invasive breast carcinoma16.10.01.005; 21.05.01.013--Not Available
Complication associated with device08.07.01.011--Not Available
Liver function test increased13.03.01.044--Not Available
Frustration tolerance decreased19.04.02.0160.000139%Not Available
Genito-pelvic pain/penetration disorder19.08.05.006; 21.03.02.022--Not Available
Bacterial vaginosis11.02.01.026; 21.14.02.0120.000209%Not Available
Cystitis klebsiella11.02.03.004; 20.03.02.0080.000139%Not Available
Oestradiol decreased13.10.05.0270.000209%Not Available
Vaginal laceration12.01.15.009; 18.07.04.006; 21.08.01.0150.000139%Not Available
Chemical burn of skin12.03.02.007; 23.03.05.0070.000139%Not Available
Oestradiol abnormal13.10.05.0260.000139%Not Available
Stress urinary incontinence20.02.02.0220.000139%Not Available
Dermal absorption impaired08.06.01.030; 23.03.03.0640.000139%Not Available
The 17th Page    First    Pre   17    Total 17 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene